TRANSIENT HEPATIC ATTENUATION DIFFERENCES

This adverse event was reported 6 times

TRANSIENT HEPATIC ATTENUATION DIFFERENCES is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LONCASTUXIMAB TESIRINE 1 0.0024
1 CALCIFEDIOL 1 0.0004
2 FAM-TRASTUZUMAB DERUXTECAN-NXKI 1 0.0001
3 AMIODARONE HYDROCHLORIDE 1 0.0001
4 TAPENTADOL HYDROCHLORIDE 1 0.0000
5 DOCUSATE SODIUM 1 0.0000
6 METFORMIN HYDROCHLORIDE TABLETS 1 0.0000
7 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 1 0.0000
8 METFORMIN HYDROCHLORIDE TABLET 1 0.0000
9 METFORMIN HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with TRANSIENT HEPATIC ATTENUATION DIFFERENCES

TRANSIENT HEPATIC ATTENUATION DIFFERENCES is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Opioid Agonist [EPC] 1 0.0000
1 Factor Xa Inhibitor [EPC] 1 0.0000
2 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
3 Loop Diuretic [EPC] 1 0.0000
4 Proton Pump Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 1 0.0000
6 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with TRANSIENT HEPATIC ATTENUATION DIFFERENCES